Scarica l'app Stockscreener
320.37
4.04%
-13.50
Dopo l'orario di chiusura:
324.19
3.82
+1.19%
Precedente Chiudi:
$333.87
Aprire:
$332.84
Volume 24 ore:
419.13K
Relative Volume:
1.56
Capitalizzazione di mercato:
$35.45B
Reddito:
$4.98B
Utile/perdita netta:
$69.59M
Rapporto P/E:
616.45
EPS:
0.5197
Flusso di cassa netto:
$525.67M
1 W Prestazione:
+5.45%
1M Prestazione:
-1.87%
6M Prestazione:
+31.05%
1 anno Prestazione:
+80.10%
Intervallo 1D:
$317.97
$332.84
Intervallo di 1 settimana:
$304.78
$335.32
Portata 52W:
$174.74
$385.22
Beone Medicines Ltd Adr Stock (ONC) Company Profile
Nome
Beone Medicines Ltd Adr
Settore
Industria
Telefono
41-616851900
Indirizzo
C/O BEONE MEDICINES I GMBH, BASEL
Confronta ONC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ONC
Beone Medicines Ltd Adr
|
320.37 | 36.95B | 4.98B | 69.59M | 525.67M | 0.5197 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
Beone Medicines Ltd Adr Stock (ONC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-24 | Iniziato | Truist | Buy |
| 2025-09-18 | Iniziato | Barclays | Overweight |
| 2025-04-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2025-03-03 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-12-03 | Ripresa | Morgan Stanley | Overweight |
| 2024-09-18 | Iniziato | JMP Securities | Mkt Outperform |
| 2024-02-06 | Ripresa | JP Morgan | Overweight |
| 2023-09-12 | Iniziato | Macquarie | Outperform |
| 2023-08-17 | Iniziato | Jefferies | Buy |
| 2023-07-17 | Iniziato | Citigroup | Buy |
| 2023-06-30 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2023-01-12 | Iniziato | Daiwa Securities | Buy |
| 2022-10-13 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2022-10-13 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2022-08-09 | Ripresa | JP Morgan | Overweight |
| 2022-03-17 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2022-02-07 | Iniziato | Deutsche Bank | Buy |
| 2021-10-12 | Iniziato | Bernstein | Outperform |
| 2021-10-06 | Aggiornamento | CLSA | Underperform → Buy |
| 2021-03-08 | Iniziato | China Renaissance | Buy |
| 2021-03-01 | Downgrade | CLSA | Outperform → Underperform |
| 2020-11-09 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2020-11-06 | Downgrade | Maxim Group | Buy → Hold |
| 2020-11-06 | Downgrade | Piper Sandler | Neutral → Underweight |
Mostra tutto
Beone Medicines Ltd Adr Borsa (ONC) Ultime notizie
Ziihera® (zanidatamab-hrii) Combinations Achieve Unprecedented Results in First-Line HER2+ Locally Advanced or Metastatic GEA including more than Two Years Median Overall Survival Benefit - GlobeNewswire Inc.
BeOne Medicines Ltd. – Sponsored ADR (NASDAQ:ONC) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
BeOne Medicines Ltd.Sponsored ADR (NASDAQ:ONC) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Voya Investment Management LLC Raises Holdings in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma - Chartmill
John Oyler Sells 75,631 Shares of BeOne Medicines (NASDAQ:ONC) Stock - MarketBeat
BeOne Medicines (NASDAQ:ONC) CEO John Oyler Sells 24,369 Shares - MarketBeat
BeOne Medicines (NASDAQ:ONC) Shares Gap Down After Insider Selling - Defense World
BeOne Medicines (NASDAQ:ONC) Shares Gap Down Following Insider Selling - MarketBeat
LMR Partners LLP Acquires New Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
China Universal Asset Management Co. Ltd. Makes New Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BeOne Medicines (NASDAQ:ONC) SVP Sells $107,900.00 in Stock - MarketBeat
35,910 Shares in BeOne Medicines Ltd. – Sponsored ADR $ONC Purchased by Axa S.A. - Defense World
Bellevue Group AG Makes New $9.37 Million Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
35,910 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Purchased by Axa S.A. - MarketBeat
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases Shares of 9,377 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
12,338 Shares in BeOne Medicines Ltd. – Sponsored ADR $ONC Purchased by American Century Companies Inc. - Defense World
8,037 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Acquired by Guggenheim Capital LLC - MarketBeat
First Trust Advisors LP Makes New Investment in BeOne Medicines Ltd. – Sponsored ADR $ONC - Defense World
First Trust Advisors LP Makes New Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
12,338 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Purchased by American Century Companies Inc. - MarketBeat
Temasek Holdings Private Ltd Acquires New Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Nan Fung Group Holdings Ltd Makes New $3.81 Million Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Jump Financial LLC Invests $17.02 Million in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Russell Investments Group Ltd. Acquires Shares of 13,603 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
7,707 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Bought by Tema Etfs LLC - MarketBeat
Walleye Capital LLC Purchases Shares of 36,645 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
467,590 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Bought by Marshall Wace LLP - MarketBeat
3,330 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Bought by Qtron Investments LLC - MarketBeat
Baird Financial Group Inc. Invests $82.90 Million in BeOne Medicines Ltd. – Sponsored ADR $ONC - Defense World
Hsbc Holdings PLC Invests $4.99 Million in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Geode Capital Management LLC Acquires New Holdings in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BeOne Medicines Ltd. – Sponsored ADR (NASDAQ:ONC) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
Baird Financial Group Inc. Invests $82.90 Million in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Mackenzie Financial Corp Purchases Shares of 41,328 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Corazon (Corsee) Sanders Sells 2,627 Shares of BeOne Medicines (NASDAQ:ONC) Stock - Defense World
Franklin Resources Inc. Purchases Shares of 16,254 BeOne Medicines Ltd. – Sponsored ADR $ONC - Defense World
Franklin Resources Inc. Purchases Shares of 16,254 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BeOne Medicines (NASDAQ:ONC) Director Corazon (Corsee) Sanders Sells 2,627 Shares - MarketBeat
Virtus Investment Advisers LLC Invests $389,000 in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Legal & General Group Plc Buys Shares of 57,243 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Jefferies Financial Group Inc. Purchases Shares of 2,900 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
PNC Financial Services Group Inc. Makes New $228,000 Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
5,981 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Purchased by Creative Planning - MarketBeat
16,300 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Acquired by Pinpoint Asset Management Singapore Pte. Ltd. - MarketBeat
Edmond DE Rothschild Holding S.A. Invests $9.93 Million in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BeOne Medicines (NASDAQ:ONC) Now Covered by Truist Financial - Defense World
Barings LLC Buys New Holdings in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Long Corridor Asset Management Ltd Invests $11.50 Million in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
ProShare Advisors LLC Makes New $373,000 Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Artisan Partners Limited Partnership Makes New $65.40 Million Investment in BeOne Medicines Ltd. – Sponsored ADR $ONC - Defense World
Beone Medicines Ltd Adr Azioni (ONC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.26%
4.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):